A detailed history of Rafferty Asset Management, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 340,469 shares of TGTX stock, worth $11 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
340,469
Previous 336,964 1.04%
Holding current value
$11 Million
Previous $5.99 Million 32.85%
% of portfolio
0.03%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$17.21 - $25.28 $60,321 - $88,606
3,505 Added 1.04%
340,469 $7.96 Million
Q2 2024

Aug 13, 2024

SELL
$13.32 - $19.19 $2.79 Million - $4.02 Million
-209,555 Reduced 38.34%
336,964 $5.99 Million
Q1 2024

May 13, 2024

SELL
$13.02 - $21.3 $320,383 - $524,129
-24,607 Reduced 4.31%
546,519 $8.31 Million
Q4 2023

Feb 13, 2024

SELL
$6.68 - $18.81 $1.91 Million - $5.37 Million
-285,711 Reduced 33.34%
571,126 $9.75 Million
Q3 2023

Nov 13, 2023

BUY
$8.36 - $26.5 $4.63 Million - $14.7 Million
554,309 Added 183.23%
856,837 $7.16 Million
Q2 2023

Aug 11, 2023

SELL
$15.48 - $35.0 $2.79 Million - $6.32 Million
-180,507 Reduced 37.37%
302,528 $7.51 Million
Q1 2023

May 11, 2023

SELL
$10.23 - $19.34 $2.75 Million - $5.2 Million
-268,744 Reduced 35.75%
483,035 $7.26 Million
Q4 2022

Feb 13, 2023

SELL
$5.01 - $11.83 $107,369 - $253,528
-21,431 Reduced 2.77%
751,779 $8.89 Million
Q3 2022

Nov 14, 2022

BUY
$4.57 - $8.4 $739,448 - $1.36 Million
161,805 Added 26.46%
773,210 $4.58 Million
Q2 2022

Aug 12, 2022

BUY
$3.74 - $10.66 $14,137 - $40,294
3,780 Added 0.62%
611,405 $2.6 Million
Q1 2022

May 13, 2022

BUY
$7.81 - $20.45 $2.26 Million - $5.92 Million
289,391 Added 90.94%
607,625 $5.78 Million
Q4 2021

Feb 10, 2022

BUY
$15.2 - $35.51 $3.25 Million - $7.59 Million
213,638 Added 204.25%
318,234 $6.05 Million
Q3 2021

Nov 10, 2021

BUY
$21.78 - $40.45 $773,995 - $1.44 Million
35,537 Added 51.46%
104,596 $3.48 Million
Q2 2021

Aug 10, 2021

BUY
$32.5 - $48.96 $71,337 - $107,467
2,195 Added 3.28%
69,059 $2.68 Million
Q1 2021

May 10, 2021

BUY
$41.61 - $54.3 $1.86 Million - $2.43 Million
44,811 Added 203.2%
66,864 $3.22 Million
Q4 2020

Feb 10, 2021

SELL
$25.27 - $54.9 $1.46 Million - $3.16 Million
-57,600 Reduced 72.31%
22,053 $1.15 Million
Q3 2020

Nov 13, 2020

BUY
$18.49 - $27.24 $445,535 - $656,375
24,096 Added 43.37%
79,653 $2.13 Million
Q2 2020

Aug 07, 2020

BUY
$8.9 - $21.84 $398,987 - $979,087
44,830 Added 417.92%
55,557 $1.08 Million
Q1 2020

May 15, 2020

SELL
$7.14 - $15.99 $573,599 - $1.28 Million
-80,336 Reduced 88.22%
10,727 $106,000
Q4 2019

Feb 10, 2020

SELL
$5.1 - $11.2 $725,612 - $1.59 Million
-142,277 Reduced 60.97%
91,063 $1.01 Million
Q3 2019

Nov 14, 2019

SELL
$5.38 - $8.99 $427,349 - $714,102
-79,433 Reduced 25.4%
233,340 $1.31 Million
Q2 2019

Aug 09, 2019

BUY
$6.27 - $8.65 $1.01 Million - $1.39 Million
160,887 Added 105.93%
312,773 $2.71 Million
Q1 2019

May 15, 2019

BUY
$4.02 - $8.04 $610,581 - $1.22 Million
151,886 New
151,886 $1.22 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.68B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.